Loxo Oncology

AmideBio LLC, located in Louisville, CO, is a leading biotechnology company specializing in the development of novel peptides for targeting metabolic diseases. With a focus on drug discovery and custom synthesis, AmideBio offers a wide range of peptide products and services to meet the needs of the pharmaceutical industry. Driven by a commitment to innovation and collaboration, AmideBio is dedicated to providing high-quality peptides that address the growing demand for effective treatments in the field of metabolic disease. With a team of experienced professionals and state-of-the-art facilities, AmideBio is at the forefront of peptide research and development, offering cutting-edge solutions to improve patient outcomes.Generated from the website

We engineer true CBD microemulsions that maximize the effects of hemp extract by delivering it straight into the bloodstream using Quicksilver Delivery System liposome technology